Detection of activated complement complex C5b-9 and complement receptor C5a in skin biopsies of patients with systemic sclerosis (scleroderma)

Journal of Rheumatology

Volumn 27, Issue 2, 2000, Pages 402-404

  Sprott, Haiko ^a   Müller Ladner, Ulf ^b   Distler, Oliver ^b   Gay, Renate E ^b   Barnum, Scott R ^b   Landthaler, Michael ^b   Schölmerich, Jürgen ^b   Lang, Bernhard ^b   Gay, Steffen ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NONE

Author keywords

Complement; Platelet Derived Growth Factor; Scleroderma; Skin

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5B;

ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; RECEPTOR UPREGULATION; SCLERODERMA; SKIN BIOPSY;

ANTIGENS, CD; BIOPSY; COMPLEMENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; HUMANS; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; SCLERODERMA, SYSTEMIC; SKIN;

EID: 0343384264     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Wild G, Watkins J, Ward AM, Hughes P, Hume A, Rowell NR. Complement activation in systemic sclerosis. J Clin Lab Immunol 1990;31:39-41.
2. Senaldi G, Vergani D, McWhirter A, Black CM. Complement activation in progressive systemic sclerosis [letter]. Lancet 1987;1:1143-4.
3. Senaldi G, Lupoli S, Vergani D, Black CM. Activation of the complement system in systemic sclerosis. Relationship to clinical severity. Arthritis Rheum 1989;32:1262-7.
4. Benbassat C, Schlesinger M, Luderschmidt C, Valentini G, Tirri G, Shoenfeld Y. The complement system and systemic sclerosis. Immunol Res 1993;12:312-6.
5. Venneker GT, van den Hoogen FH, Boerbooms AM, Bos JD, Asghar SS. Aberrant expression of membrane cofactor protein and decay-accelerating factor in the endothelium of patients with systemic sclerosis. A possible mechanism of vascular damage. Lab Invest 1994;70:830-5.
6. Nangaku M, Meek RL, Pippin J, et al. Transfected CD59 protects mesangial cells from injury induced by antibody and complement. Kidney Int 1996;50:257-66.
7. Gay S, Jones RE Jr, Huang GQ, Gay RE. Immunohistologic demonstration of platelet-derived growth factor and sis-oncogene expression in scleroderma. J Invest Dermatol 1989;92:301-3.
8. Benzaquen LR, Nicholson-Weller A, Halperin JA. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells. J Exp Med 1994;179:985-92.
9. Kriegsmann J. Keyszer GM, Geiler T, Bräuer R, Gay RE, Gay S. Expression of vascular cell adhesion molecule-1 mRNA and protein in rheumatoid synovium demonstrated by in situ hybridization and immunohistochemistry. Lab Invest 1995;72:209-14.
10. Gay S, Fine JD. Immunization, characterization and isolation of poly- and monoclonal antibodies against collagen for use in immunohistochemistry. In: Cunningham LW; editor. Methods in enzymology. New York: Academic Press; 1987;145:148-67.
11. von Bierbrauer AF, Mennel HD, Schmidt JA, von Wiehert P. Intravital microscopy and capillaroscopically guided nailfold biopsy in scleroderma. Ann Rheum Dis 1996;55:305-10.
12. Nicoletti A, Mandet C, Challah M, Bariety J, Michel JB. Mediators of perivascular inflammation in the left ventricle of renovascular hypertensive rats. Cardiovasc Res 1996;31:585-95.
13. Rudnicka L, Varga J, Christiano AM, Iozzo RV, Jimenez SA, Uitto J. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta. J Clin Invest 1994;93:1709-15.
14. Klareskog L, Gustafsson R, Scheynius A, Hallgren R. Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis Rheum 1990;33:1534-41.